Form 4: ClearPoint Neuro CEO Vests RSUs, Covers Taxes
Insider Transaction Report
ClearPoint Neuro, Inc. CEO and President Joseph Burnett acquired 26,568 shares of common stock through RSU vesting and disposed of 9,533 shares to cover tax obligations.
Summary
- Joseph Burnett, CEO and President of ClearPoint Neuro, Inc., acquired 26,568 shares of common stock on March 3, 2026, through the settlement of restricted stock units.
- Concurrently, 9,533 shares were disposed of at a price of $8.84 per share to satisfy tax withholding obligations related to the RSU vesting.
- Following these transactions, Burnett directly holds 29,534 shares of common stock and indirectly holds 193,231 shares through the Joseph M. Burnett Trust.
- Burnett also beneficially owns 106,273 derivative Restricted Stock Units.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, representing a routine compensation transaction for an executive, with no significant positive or negative implications for the company's operational or financial performance.
Positives
- CEO Joseph Burnett continues to hold a significant number of shares, demonstrating ongoing alignment with shareholder interests.
- The vesting of restricted stock units indicates the achievement of previously set performance or time-based criteria.
Negatives
- A portion of the vested shares (9,533 shares) was sold to cover tax liabilities, which is a common practice but reduces direct ownership.
Industry Context
StockSavvy.ai notes that routine insider transactions like RSU vesting and tax-related sales are common across all industries, particularly for executives in publicly traded companies. This filing reflects standard compensation practices rather than a strategic market move.
Stakeholder Impact
- Shareholders: Minimal direct impact as this is a routine compensation event, but it confirms continued insider ownership.
- Employees: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 10/20/2022 | Date of the Joseph M. Burnett Trust. |
| 03/03/2026 | Date of RSU vesting and related stock transactions. |
| 03/05/2026 | Date the Form 4 was signed by Power of Attorney. |
Keywords
ClearPoint Neuro, CLPT, Joseph Burnett, Insider Transaction, Form 4, Restricted Stock Units, RSU Vesting, Stock Ownership, CEO, Director
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.